Clinical Trials in Boston

Showing 8121-8140 of 17,836 trials

Ferumoxytol-enhanced Magnetic Resonance Imaging

NCT02954510

There are no current alternatives to diagnostic contrast-requiring imaging for patients with an eGFR \<30mL/min due to the association of gadolinium-based imaging modalities to nephrogenic systemic fibrosis and iodinated contrast-induced kidney injury. Ferumoxytol-enhanced imaging may offer an alternative approach.

Coronary Artery Disease

Brigham and Women's Hospital185 participantsStarted Feb 2017

Boston, Massachusetts, United States

TERMINATEDPhase 3< 1 mile

Reduced Intensity Regimen vs Myeloablative Regimen for Myeloid Leukemia or Myelodysplastic Syndrome (BMT CTN 0901)

NCT01339910

The study is designed as a Phase III, multicenter trial comparing outcomes after allogeneic hematopoietic stem cell transplantation (HCT) for acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) between patients receiving myeloablative conditioning (MAC) versus reduced intensity conditioning (RIC) regimens.

Leukemia, Myelocytic, Acute

Medical College of Wisconsin272 participantsStarted Jun 2011

Phoenix, Arizona, United States • La Jolla, California, United States • Gainesville, Florida, United States +29 more locations

Ferumoxytol-enhanced Magnetic Resonance Imaging

Reduced Intensity Regimen vs Myeloablative Regimen for Myeloid Leukemia or Myelodysplastic Syndrome (BMT CTN 0901)

Find Trials by Condition in Boston

Trial on Endovascular Aneurysm Management

Meditation and Opioid Consumption in Total Joint Replacement Patients Undergo Primary Total Hip and Knee Replacement

Addition of X4P-001 to Nivolumab Treatment in Participants With Renal Cell Carcinoma

Multicenter,Single-arm Study to Evaluate Efficacy, Safety, & Pharmacokinetics of Denosumab in Children w/ OI

OLAParib COmbinations

REPRISE IV: LOTUS Edge Valve System in Intermediate Surgical Risk Subjects

Safety and Efficacy of APX005M With Gemcitabine and Nab-Paclitaxel With or Without Nivolumab in Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma

A Study to Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold Agglutinin Disease Without A Recent History of Blood Transfusion

Neuromodulation of Lidocaine Cream Effect on Chronic Pain Patients

Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma

Study Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the Pancreas

Initiating and Maintaining Physical Activity in Depressed Individuals

A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma

Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse

A Study of Venetoclax and Dinaciclib (MK7965) in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Validation of Dyskinesia Rating Scales

Long-term, Open-label, Flexible-dose, Extension Study of Vortioxetine in Child and Adolescent Participants With Major Depressive Disorder (MDD) From 7 to 18 Years of Age

A Rollover Study to Provide Continued Treatment With Eltrombopag